Filters close
Newswise: Tube-eeze Patches Revolutionize Accessibility for Babies with Medical Equipment
Released: 19-Mar-2024 1:05 PM EDT
Tube-eeze Patches Revolutionize Accessibility for Babies with Medical Equipment
Tabeeze

Babies with medical devices such as g-tubes, j-tubes, PICC lines, ports, and more often face challenges in finding suitable clothing that accommodates their needs.

Released: 7-Mar-2024 10:05 AM EST
Parrish Medical Center Becomes a Cleveland Clinic Connected Member
Cleveland Clinic

CLEVELAND, OH and TITUSVILLE, FL: Cleveland Clinic and Parrish Medical Center, a Parrish Healthcare integrated care partner, jointly announced that Parrish Medical Center has become a member of Cleveland Clinic Connected.

   
Newswise: Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing
Released: 20-Feb-2024 7:55 AM EST
Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing
Avails Medical, Inc.

Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.

Released: 13-Feb-2024 10:05 AM EST
Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers
Wasatch BioLabs

Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies' laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers.

   
Released: 7-Feb-2024 9:05 AM EST
CSA Medical Announces 500th Metered CryoSpray Procedure for the Treatment of Chronic Bronchitis
CSA Medical

The RejuvenAir System is a minimally invasive medical device therapy which aims to target the underlying cause of COPD with Chronic Bronchitis.

Released: 6-Feb-2024 9:05 AM EST
Koning Health's Revolutionary Vera Breast CT Impresses at Arab Health in Dubai
Koning Corporation

Koning Health, a pioneer in advanced medical imaging technology, is proud to announce the successful showcasing of the Koning Vera Breast CT at the prestigious Arab Health exhibition in Dubai.

Released: 1-Feb-2024 2:05 PM EST
Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
Stuart Therapeutics

Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.

Released: 30-Jan-2024 11:05 AM EST
Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program
Harmonic Discovery

Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive licensing agreement of a novel small-molecule drug candidate for the treatment of FLT3 mutated acute myeloid leukemia (AML) from BioVentures (University of Arkansas for Medical Sciences) and UC San Francisco (UCSF).

Released: 24-Jan-2024 12:05 PM EST
FDA purchases digiM I2S software for the assessment of product quality attributes
digiM Solution

The U.S. Food and Drug Administration has placed a purchase order (75F40123P00369) committing to an annual subscription of digiM I2S, a fully integrated image processing platform based on digiM's proprietary cloud technology.

Released: 23-Jan-2024 2:05 PM EST
People with dementia or other forms of cognitive impairment smile, sing, and even dance with headphones on
Quiet Events Inc.

Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.

Released: 12-Jan-2024 8:05 AM EST
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Darmiyan

FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.

Released: 11-Jan-2024 12:05 PM EST
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
Rockland Immunochemicals, Inc

The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.

Released: 8-Jan-2024 1:05 PM EST
Comprehensive Care Services Acquires Life Systems to Become Global Perfusion Leader
Comprehensive Care Services

omprehensive Care Services (CCS) has become the world's largest perfusion provider with the acquisition of German-based Life Systems. This move unites two leaders in perfusion care, expanding global access to top-tier patient services.

Released: 20-Dec-2023 1:05 PM EST
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
Superfluid Dx

WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ Sciences has acquired majority ownership in the Alzheimer's Disease (AD) diagnostics company, Molecular Stethoscope, Inc., which is now renamed Superfluid Diagnostics, Inc. The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) participated in the Series A financing.

Released: 5-Dec-2023 2:05 PM EST
Koning Health Showcases Groundbreaking Breast CT Technology at RSNA 2023
Koning Corporation

Koning Health, a leader in innovative breast imaging technology, is proud to announce its triumphant participation at the Radiological Society of North America (RSNA) 2023 Annual Meeting. The event, renowned for its educational courses, scientific sessions, and technical exhibits, provided an ideal platform for Koning to showcase its revolutionary product, the Koning Vera Breast CT.

Newswise: Orange Photonics Unveils LightLab 3 Psy Analyzer, Revolutionizing Analytical Testing for Psychedelic Mushrooms and Infused Products
Released: 19-Oct-2023 9:25 AM EDT
Orange Photonics Unveils LightLab 3 Psy Analyzer, Revolutionizing Analytical Testing for Psychedelic Mushrooms and Infused Products
Orange Photonics

Orange Photonics, a pioneer in analytical testing solutions, is pleased to introduce LightLab 3 Psy Analyzer

Newswise: Buddy Abroad game helps students navigate travel and wellness
Released: 18-Oct-2023 2:05 PM EDT
Buddy Abroad game helps students navigate travel and wellness
DePaul University

DePaul University will publish and sell the game to help study abroad students prepare for traveling and learning internationally, focusing on practical tips as well as maintaining health and wellness.

Released: 17-Oct-2023 1:05 PM EDT
Rockland Launches Novel Analytical Tools to Assess Drug Delivery: Revolutionizing Oligonucleotide Therapeutic Development
Rockland Immunochemicals, Inc

The first and only panel of specialty reagents designed to detect PS modifications independent of sequence, format, or location, streamlining candidate triage for unparalleled cost and time savings in non-clinical/pre-clinical discovery assessment of oligonucleotide drug candidates, clinical trials for immunogenicity studies, and other applications.

Released: 17-Oct-2023 11:05 AM EDT
Wren Laboratories Expands Flagship Molecular Cancer Diagnostic NETest to China
Wren Laboratories

Licensing agreement with Kindstar Globalgene Technology will more than double Wren NETest distribution within first year

Released: 16-Oct-2023 3:00 PM EDT
Werfen Receives US FDA 510(K) Clearance for Aptiva® Connective Tissue Disease Essential Reagent
Werfen

New Reagent Aids in Diagnosis of Connective Tissue Disease in Hard-to-Diagnose Autoimmune Diseases, Reducing Time to Diagnosis and Improving Patient Outcomes

Released: 11-Oct-2023 10:05 AM EDT
Tau Systems Enhances Management Team with Business Development and Laser Technology Appointments
TAU Systems

TAU Systems, the producer of ultrafast, compact laser-plasma accelerators, today announced further additions to its senior management team as the company continues on its path to commercial availability of the system.

Released: 2-Oct-2023 9:25 AM EDT
ARUP's New Institute for Research and Innovation in Diagnostic and Precision Medicine™ Will Forge the Future of Laboratory Medicine
ARUP Laboratories

ARUP Laboratories today announced the formation of the new ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute). The institute will improve the lives of patients by advancing groundbreaking diagnostic and prognostic technologies and innovative tests.

   
Newswise: American Dental Hygienists’ Association Partners with Colgate® for October’s National Dental Hygiene Month 2023
Released: 25-Sep-2023 5:05 PM EDT
American Dental Hygienists’ Association Partners with Colgate® for October’s National Dental Hygiene Month 2023
American Dental Hygienists' Association and Colgate® Oral Pharmaceuticals

The ADHA® renews its partnership with Colgate® Oral Pharmaceuticals, Inc. for National Dental Hygiene Month 2023, to honor all dental hygienists throughout October. This year’s theme, "Everyday Extraordinary," celebrates dental hygienists who transform everyday tasks with extraordinary expertise.

Released: 19-Sep-2023 10:05 AM EDT
Quanta Announces FDA 510(k) Submission for Home Use of Quanta Dialysis System
Quanta Dialysis Technologies

New expanded indication will increase home hemodialysis device options available to patients with end-stage kidney disease.

Released: 24-Aug-2023 11:30 AM EDT
Altis Biosystems Launches RepliGut® Planar InflammaScreen Services to Accelerate Drug Discovery for Inflammatory Bowel Diseases
Altis Biosystems

Altis Biosystems, a leader in developing innovative, in vitro cell-based model systems for drug discovery, announces the launch of RepliGut® Planar InflammaScreen™ Services.

Released: 10-Aug-2023 8:05 AM EDT
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa
Rakuten Medical, Inc.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform today announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company for the Middle East and North Africa (MENA).

Released: 1-Aug-2023 4:05 PM EDT
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
Waters Corporation

Waters Corporation (NYSE:WAT) introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

   
Released: 31-Jul-2023 4:15 PM EDT
Endocrine Society and Matchbox Virtual Media Announce Joint Venture
Endocrine Society

The Endocrine Society and Matchbox Virtual Media are pleased to announce today that the organizations formed a joint venture that will bring exciting new opportunities for medical, healthcare, and scientific associations to better customize the experiences of their customers relative to producing meetings, organizing communities, and disseminating educational products.

Newswise: At an event in California, a Brazilian health tech company presented its exclusive technology for blood tests with AI, delivering results within 30 minutes
Released: 21-Jul-2023 4:20 PM EDT
At an event in California, a Brazilian health tech company presented its exclusive technology for blood tests with AI, delivering results within 30 minutes
2023 AACC Annual Scientific Meeting Press Program

During the AACC - Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, California (USA) from July 23rd to 27th, the Brazilian health tech company Hilab, specializing in clinical analysis tests, participated in the congress alongside ABIMO - Brazilian Association of Medical Devices Industry.

   


close
0.2329